Urologix' Targis
This article was originally published in The Gray Sheet
Executive Summary
Production of the microwave-based system for benign prostatic hyperplasia begins at Plexus Corp. under a two-year manufacturing agreement announced Oct. 24. Initial deliveries from Plexus are slated for December. Quality system deficiencies have hampered production at Colorado MEDtech under a previous arrangement (1"The Gray Sheet" Aug. 13, 2001, p. 13). Minneapolis-based Urologix continues to develop redundant, in-house manufacturing facilities for the device, approved by FDA in 1997, and expects completion by mid-2002